NinePointTwo Capital’s Altimmune ALT Stock Holding History

NinePointTwo Capital’s Portfolio ALT Stock Details ALT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-60,482	Closed	-$255K	–	245
2023 Q1	$255K	Buy	60,482 +44,535	+279%	+$529K	0.1%	122
2022 Q4	$262K	Buy	+15,947	New	+$179K	0.11%	50
2022 Q1	–	Sell	-37,168	Closed	-$340K	–	222
2021 Q4	$340K	Buy	+37,168	New	+$395K	0.11%	40

Other funds holding ALT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AAP

Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

NinePointTwo Capital's ALT Position: Q2 2023 in Review

NinePointTwo Capital sold out of Altimmune (ALT) in Q2 2023, closing a stake of 60,482 shares — an estimated $255K sold.

NinePointTwo Capital first reported a position in ALT in Q4 2021 and held it in 3 quarters. The position peaked at $340K in Q4 2021. 120 funds tracked by Wall St. Rank hold ALT as of Q2 2023.

NinePointTwo Capital reported no remaining Altimmune position as of Q2 2023 after selling out during the quarter.
NinePointTwo Capital sold 60,482 Altimmune shares in Q2 2023, an estimated $255K.
NinePointTwo Capital first reported a position in Altimmune in Q4 2021 and held it in 3 quarters.
NinePointTwo Capital's Altimmune position peaked at $340K in Q4 2021.
120 funds tracked by Wall St. Rank held Altimmune as of Q2 2023.

Based on NinePointTwo Capital's 13F filing for Q2 2023, filed 14 Aug 2023.